Biomarin Pharmaceutical (BMRN) Other Non-Current Assets (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported Other Non-Current Assets of $338.14 million for Q2 2026, up 35.7% from $249.19 million a year earlier but down 60.2% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical posted Other Non-Current Assets of $277.05 million, up 10.2% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $251.39 million in FY2024 (+46.6%), $171.54 million in FY2023 (-2.7%), $176.24 million in FY2022 (+15.9%) and $152.12 million in FY2021 (+6.9%).
- Five-year quarterly Other Non-Current Assets spans a low of $144.17 million in Q2 2023 and a high of $850 million in Q1 2026.
- Year over year, Other Non-Current Assets has now increased in each of the last ten quarters, with growth averaging 58.5% over the last eight quarters.
- The high point for year-over-year Other Non-Current Assets in five years was Q1 2026 (growth of 260.7%); the low point was Q2 2023 (a decline of 5.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $850 million (Q1 2026), $277.05 million (Q4 2025) and $270.78 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 338.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 338.14 Mn |
| Mar 31, 2026 | 850.00 Mn |
| Dec 31, 2025 | 277.05 Mn |
| Sep 30, 2025 | 270.78 Mn |
| Jun 30, 2025 | 249.19 Mn |
| Mar 31, 2025 | 235.65 Mn |
| Dec 31, 2024 | 251.39 Mn |
| Sep 30, 2024 | 199.31 Mn |
| Jun 30, 2024 | 190.77 Mn |
| Mar 31, 2024 | 184.79 Mn |
| Dec 31, 2023 | 171.54 Mn |
| Sep 30, 2023 | 165.07 Mn |
| Jun 30, 2023 | 144.17 Mn |
| Mar 31, 2023 | 150.06 Mn |
| Dec 31, 2022 | 176.24 Mn |
| Sep 30, 2022 | 151.79 Mn |
| Jun 30, 2022 | 151.80 Mn |
| Mar 31, 2022 | 149.19 Mn |
| Dec 31, 2021 | 152.12 Mn |
| Sep 30, 2021 | 144.71 Mn |
Biomarin Pharmaceutical Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();